Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center Journal Article


Authors: Anderlini, P.; Saliba, R.; Acholonu, S.; Okoroji, G. J.; Ledesma, C.; Andersson, B. S.; Jones, R.; Popat, U. R.; Hosing, C. M.; Nieto, Y.; Qazilbash, M. H.; Ueno, N. T.; Giralt, S. A.; De Lima, M. J.; Champlin, R. E.
Article Title: Donor leukocyte infusions in recurrent Hodgkin lymphoma following allogeneic stem cell transplant: 10-year experience at the M. D. Anderson Cancer Center
Keywords: adult; cancer survival; treatment response; middle aged; retrospective studies; transplantation, homologous; young adult; fludarabine; allogeneic stem cell transplantation; cancer recurrence; salvage therapy; letter; recurrence; cyclophosphamide; melphalan; stem cell transplantation; cancer mortality; hodgkin disease; time factors; cancer care facilities; donor lymphocyte infusion; texas; panobinostat; alemtuzumab; blood donors; thymocyte antibody; leukocyte transfusion; brentuximab vedotin
Journal Title: Leukemia and Lymphoma
Volume: 53
Issue: 6
ISSN: 1042-8194
Publisher: Taylor & Francis Group  
Date Published: 2012-06-01
Start Page: 1239
End Page: 1241
Language: English
DOI: 10.3109/10428194.2011.644547
PROVIDER: scopus
PUBMED: 22132837
PMCID: PMC4493857
DOI/URL:
Notes: --- - "Export Date: 4 June 2012" - "CODEN: LELYE" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt